Humacyte | BiotechTV

top of page

Humacyte CEO Laura Niklason updates us on the early days of the launch of Symvess, the company's bioengineered blood vessel product

She describes the work the company is doing with hospitals and the military to grow uptake as the company launches the product. Plus,...

Company News

Sep 8

Humacyte's CEO demonstrates the bioengineered human arteries the company has developed and that is in front of FDA with an August decision date for its BLA

Laura Niklason shows us what Humacyte's Human Acellular Vessel (HAV) looks like, describes how it is manufactured, explains its utility,...

Tech + Tours

May 22, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page

Humacyte CEO Laura Niklason updates us on the early days of the launch of Symvess, the company's bioengineered blood vessel product

Humacyte's CEO demonstrates the bioengineered human arteries the company has developed and that is in front of FDA with an August decision date for its BLA

Follow BiotechTV

Sponsors

Sponsor Spotlight